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ABSTRACT 
Cynara scolymus (artichoke), Silybum marianum (milk thistle) and Cochlospermum 
angolensis (borututu) are three plants widely used regarding hepatoprotective effects but 
to the best of our knowledge no anti-hepatocellular carcinoma activity has been studied 
in the most consumed forms: infusions and dietary supplements. Herein, antioxidant 
properties, anti-hepatocellular carcinoma activity and toxicity of infusions and dietary 
supplements of the mentioned plants were evaluated and compared. All the samples 
revealed antioxidant properties with EC50 values lower than the daily recommended 
dose, but infusions showed higher biological activity than dietary supplements. 
Borututu infusion gave the highest antioxidant activity (EC50≤170 µg/mL), and also 
revealed anti-hepatocellular carcinoma activity (GI50=146 µg/mL) without toxicity in 
non-tumour liver cells (GI50>400 µg/mL). Artichoke infusion also presented antitumour 
activity (GI50=52 µg/mL) but with toxicity for normal cells at a higher concentration 
(GI50=72 µg/mL). The antioxidant and antitumour properties were positively correlated 
with phenolics and flavonoids content. Overall, among the three studied species, 
borututu infusion proved to be the most complete sample regarding antioxidant and anti-
hepatocellular carcinoma activity. 
 
Keywords: Medicinal plants; Infusions/Dietary supplements; Antioxidant activity; 
HepG2; toxicity  
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1. Introduction  
Artichoke (Cynara scolymus L.) is an herbaceous perennial plant native to the 
Mediterranean Basin that belongs to the Asteraceae family (Bianco, 2005). Consumed 
raw, boiled, steamed or fried, this plant is today widely cultivated all over the world for 
its large fleshy immature inflorescences, called heads or capitula, with edible leaves 
(bracts) and receptacle. Artichoke is known since ancient times as a tasty plant that can 
be used in soups, stews and salads, being perceived as a nutritious and healthy vegetable 
(Lattanzio et al., 2009) due to its antioxidant and hepatoprotective effects (Gebhardt and 
Fausel, 1997; Zapolska-Downar et al., 2002; Jimène-Escrig et al., 2003; Wang et al., 
2003; Falleh et al., 2008; Kukić et al., 2008; Gouveia and Castilho, 2012). This plant 
contains very little fat and high levels of minerals, vitamin C, fibre, inulin, polyphenols 
hydoxycinnamates and flavones, but most of its activity could be related to the 
polyphenolic fraction, mainly composed of mono- and dicaffeoylquinic acids and 
flavonoids (Schütz et al., 2004; Falleh et al., 2008; Lutz et al., 2011; Pandino et al., 
2011; Gouveia and Castilho, 2012). 
Milk thistle (Silybum marianum (L.) Gaertn) is also a member of Asteraceae family. It’s 
an annual to biennial herbaceous plant, native to the Mediterranean countries with 
reported effects against hepatotoxicity and acute and chronic liver diseases, due to its 
main pharmacological active ingredient silymarin (standard mixture of flavonoligans) 
(Giese, 2001; Zuber et al., 2002; Doehmer et al., 2011). Beyond the hepatoprotective 
activity, this flavonoid complex also has antioxidant properties which seem to be related 
to liver damage prevention (Nencini et al., 2007; Shaker et al., 2010). Silibinin, the 
major active constituent of silymarin, has been reported as inhibitor of tumour growth in 
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hepatocarcinoma cell (Brandon-Warner et al., 2010) and animal (Bousserouel et al., 
2012) models.  
Borututu (Cochlospermum angolensis Welw.) is a widespread tree in Angola that 
belongs to the Cochlospermaceae family. Its bark infusion is used in the traditional 
medicine of Angola for the treatment of hepatic diseases and for the prophylaxis of 
malaria (Poppendieck, 1981; Presber et al., 1991; Silva et al., 2011). Phenolic 
composition of borututu hydromethanolic and aqueous extracts were recently 
characterized and revealed to be rich in methyl ellagic acid and ellagic acid, respectively 
(Ferreres et al., 2013). The infusion of its dry roots also showed high 2,2-diphenyl-1-
picrylhydrazyl (DPPH) scavenging activity (Costa et al., 2012).  
Despite the described hepatoprotective effects of the three mentioned plants and a few 
reports on their anti-hepatocellular carcinoma activity (Miccadei et al., 2008; Brandon-
Warner et al., 2010), studies with the most consumed forms (infusions and dietary 
supplements) are scarce. Hepatocellular carcinoma is a major health problem with more 
than 660,000 new cases per year worldwide, being a rapid fatal disease with a life 
expectancy of about 6 months from the time of diagnostics; it has the third highest 
mortality rate among all cancers (Jemal et al., 2011).  In the present work, infusions and 
dietary supplements of artichoke, milk thistle and borututu were prepared and studied 
for antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity in 
non-tumour liver primary cells. Furthermore, all these properties were correlated with 
the content in bioactive compounds.  
 
2. Material and Methods 
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2.1. Samples and samples preparation 
2.1.1. Samples. Cynara scolymus L. (artichoke), Silybum marianum (L.) Gaertn (milk 
thistle) and Cochlospermum angolensis Welw. (borututu) are plants widely used for 
their antioxidant and hepatoprotective properties. For the present study, artichoke, milk 
thistle and borututu were obtained from an herbalist shop in Bragança (Portugal), as dry 
material for infusions preparation (leaves, plant and bark, respectively; the taxonomical 
identification of plant species mentioned in the labels was confirmed) and dietary 
supplements (pills based-on plant and roots, in the case of borututu). All the samples 
were prepared according to the label and submitted to an evaluation of bioactive 
compounds (phenolics and flavonoids), antioxidant activity, anti-hepatocellular 
carcinoma activity and hepatotoxicity. 
 
2.1.2. Infusions preparation. A dry weight of each material (20 g of artichoke and 8.5 g 
of milk thistle corresponding to the recommended 4 spoons; and 10 g of borututu) was 
added to 1 L or 0.5 L (in the case of borututu) of boiling distilled water, left to stand at 
room temperature for 10 min, filtered under reduced pressure, frozen, lyophilized and 
redissolved in distilled water at a final concentration of 10 mg/mL.  The following 
dilutions were used in the biological assays: 10 mg/mL to 1.22 µg/mL for antioxidant 
activity assays; 400, 100, 25, 6.25 and 1.56 µg/mL for hepatotoxicity assays. 
 
2.1.3. Dietary supplements preparation.  Three pills of each sample (1500 mg) were 
dissolved in 100 mL of distilled water (final concentration 15 mg/mL). Several dilutions 
of each sample were prepared to perform further assays. The following dilutions were 
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used in the biological assays: 15 mg/mL to 0.23 mg/mL for antioxidant activity assays; 
400, 100, 25, 6.25 and 1.56 µg/mL for hepatotoxicity assays. 
 
2.2. Standards and reagents 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, 
USA). Gallic acid, catechin, trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid), ellipticine, phosphate buffered saline (PBS), acetic acid, 
sulforhodamine B (SRB), trichloroacetic acid (TCA) and Tris were purchased from 
Sigma (St. Louis, USA). Foetal bovine serum (FBS), L-glutamine, Hank’s balanced salt 
solution (HBSS), trypsin-EDTA (ethylenediaminetetraacetic acid), nonessential amino 
acids solution (2 mM), penicillin/streptomycin solution (100 U/mL and 100 mg/mL, 
respectively) and DMEM (Dulbecco's Modified Eagle Medium) were from Hyclone 
(Logan, USA). Water was treated in a Milli-Q water purification system (TGI Pure 
Water Systems, USA).  
 
2.3. Quantification of total bioactive compounds 
Total phenolics were estimated by Folin-Ciocalteu colorimetric assay according to 
procedures previously described (Batista et al., 2011) and the results were expressed as 
mg of gallic acid equivalents (GAE) per g of sample (lyophilized infusion or pill). 
Total flavonoids were determined by a colorimetric assay using aluminum trichloride, 
following procedures previously reported (Batista et al., 2011); the results were 
expressed as mg of (+)-catechin equivalents (CE) per g of sample (lyophilized infusion 
or pill). 
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2.4. Evaluation of antioxidant activity  
The antioxidant properties were evaluated by four different tests as there is no universal 
method that can measure the antioxidant capacity of all samples accurately and 
quantitatively: DPPH radical-scavenging activity, reducing power, inhibition of β-
carotene bleaching and inhibition of lipid peroxidation using TBARS (thiobarbituric 
acid reactive substances) in brain homogenates (Rafael et al., 2011). The results were 
expressed in EC50 values (sample concentration providing 50% of antioxidant activity 
or 0.5 of absorbance in the reducing power assay). Trolox was used as positive control. 
 
2.4.1. DPPH radical-scavenging activity. This methodology was performed using an 
ELX800 microplate Reader (Bio-Tek Instruments, Inc; Winooski, USA). The reaction 
mixture on 96 well plate consisted in the sample solutions (30 µL) and methanolic 
solution (270 µL) containing DPPH radicals (6×10-5 mol/L). The mixture was left to 
stand for 30 min in the dark, and the absorption was measured at 515 nm. The radical 
scavenging activity (RSA) was calculated as a percentage of DPPH discoloration using 
the equation: %RSA=[(ADPPH-AS)/ADPPH]×100, where AS is the absorbance of the 
solution containing the sample, and ADPPH is the absorbance of the DPPH solution. 
 
2.4.2. Reducing power. The sample solutions (0.5 mL) were mixed with sodium 
phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 
0.5 mL). The mixture was incubated at 50 °C for 20 min, and trichloroacetic acid (10% 
w/v, 0.5 mL) was added. The mixture (0.8 mL) was poured in the 48 wells plate, the 
same with deionised water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and the 
absorbance was measured at 690 nm in the Microplate Reader mentioned above. 
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2.4.3. Inhibition of β-carotene bleaching. A solution of β-carotene was prepared by 
dissolving β-carotene (2 mg) in chloroform (10 mL). Two milliliters of this solution 
were pipetted into a round-bottom flask. The chloroform was removed at 40 °C under 
vacuum and linoleic acid (40 mg), Tween 80 emulsifier (400 mg), and distilled water 
(100 mL) were added to the flask with vigorous shaking. Aliquots (4.8 mL) of this 
emulsion were transferred into test tubes containing sample solutions (0.2 mL). The 
tubes were shaken and incubated at 50 °C in a water bath. As soon as the emulsion was 
added to each tube, the zero time absorbance was measured at 470 nm. β-Carotene 
bleaching inhibition was measured by the formula: β-carotene absorbance after 
2h/initial absorbance) × 100.  
 
2.4.4. TBARS assay. Porcine (Sus scrofa) brains were obtained from official slaughtered 
animals, dissected, and homogenized with Polytron in an ice cold Tris-HCl buffer (20 
mM, pH 7.4) to produce a 1:2 w/v brain tissue homogenate which was centrifuged at 
3000g for10 min. An aliquot (100 µL) of the supernatant was incubated with the sample 
solutions (200 µL) in the presence of FeSO4 (10 mM; 100 µL) and ascorbic acid 
(0.1mM; 100 µl) at 37 °C for 1h. The reaction was stopped by the addition of 
trichloroacetic acid (28% w/v, 500 µL), followed by thiobarbituric acid (TBA, 2%, w/v, 
380 µL), and the mixture was then heated at 80 °C for 20 min. After centrifugation at 
3000g for 10 min to remove the precipitated protein, the color intensity of the 
malondialdehyde (MDA)-TBA complex in the supernatant was measured by its 
absorbance at 532 nm. The inhibition ratio (%) was calculated using the following 
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formula: Inhibition ratio (%) = [(A−B)/A] × 100%, where A and B were the absorbance 
of the control and the sample solution, respectively. 
 
2.5. Evaluation of hepatocellular carcinoma activity 
The anti-hepatocellular carcinoma activity was evaluated using HepG2, which is the 
most widely used tumour cell line and generally regarded as a good hepatocellular 
carcinoma model. HepG2 cells were routinely maintained as adherent cell cultures in 
DMEM supplemented with 10% FBS, 2 mM glutamine, 100 U/mL penicillin and 100 
mg/mL streptomycin, at 37 ºC, in a humidified air incubator containing 5% CO2. The 
cell line was plated at 1.0 × 104 cells/well in 96-well plates. Cells were then treated for 
48h with the sample solutions. Following this incubation period, the adherent cells were 
fixed by adding cold 10% trichloroacetic acid (TCA, 100 µL) and incubated for 60 min 
at 4 ºC. Plates were then washed with deionized water and dried; sulforhodamine B 
solution (0.1% in 1% acetic acid, 100 µL) was added to each plate well and incubated 
for 30 min at room temperature. Unbound SRB was removed by washing with 1% 
acetic acid. Plates were air dried, the bound SRB was solubilised with 10 mM Tris (200 
µL, pH 7.4) and the absorbance was measured at 540 nm (Guimarães et al., 2013) in the 
microplate reader mentioned above. The results were expressed in GI50 values (sample 
concentration that inhibited 50% of the net cell growth). Ellipticine was used as positive 
control.  
 
2.5. Evaluation of hepatotoxicity  
The hepatotoxicity was accessed using a non-tumour liver primary culture established in 
our laboratory (PLP2). The cell culture was prepared from a freshly harvested porcine 
liver obtained from a local slaughter house. Once in the lab, the liver tissues were rinsed 
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in Hank’s balanced salt solution containing 100 U/mL penicillin, 100 µg/mL 
streptomycin and divided into 1×1 mm3 explants. Five explants were placed in 25 cm2 
tissue flasks in DMEM medium supplemented with 10% FBS, 2 mM nonessential 
amino acids and 100 U/mL penicillin, 100 mg/mL streptomycin and incubated at 37 ºC 
with a humidified atmosphere containing 5% CO2. The medium was changed every two 
days. Cultivation of the cells was continued with direct monitoring every two to three 
days using a phase contrast microscope. Before confluence, cells were subcultured and 
plated in 96-well plates at a density of 1.0×104 cells/well, and cultivated in DMEM 
medium with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin (Guimarães 
et al., 2013). Cells were treated for 48h with the sample solutions and the same 
procedure described in the previous section for SRB assay was followed. The results 
were expressed in GI50 values (sample concentration that inhibited 50% of the net cell 
growth). Ellipticine was used as positive control. 
 
2.6. Statistical analysis 
For all the experiments three samples (n=3) were analysed and all the assays were 
carried out in triplicate. The results are expressed as mean values and standard deviation 
(SD). The differences between the different samples were analyzed using one-way 
analysis of variance (ANOVA) followed by Tukey’s honestly significant difference post 
hoc test with α = 0.05, coupled with Welch’s statistic. This treatment was carried out 
using SPSS v. 18.0 program. The regression analysis between total phenolic or 
flavonoid contents, and antioxidant activity EC50 values and anti-hepatocellular 
carcinoma activity GI50 values used the same statistical package.  
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3. Results and Discussion 
3.1. Bioactive compounds, antioxidant activity and hepatotoxicity of the infusions  
The results for infusions and dietary supplements are present in Tables 1 and 2, 
respectively.  Borututu infusion gave the highest amounts of total phenolics and 
flavonoids, as also the highest antioxidant activity in all the assays (Table 1). The 
infusions of milk thistle and artichoke revealed, in general, similar contents in phenolics 
and antioxidant activity. The much higher content of total phenolics (132.26 mg GAE/g) 
and flavonoids (17.88 mg CE/g) observed in borututu infusion might be related to the 
part of the plant used in this case (bark).  
Although there are some reports on phenolics, flavonoids and DPPH scavenging activity 
of artichoke (Jimènez-Escrig et al., 2003; Falleh et al., 2008; Kubić et al., 2008; Lutz et 
al., 2011; Gouveia and Castilho, 2012), the studies were performed in extracts and not 
in the real forms of consumption (e.g. infusions and dietary supplements as herein). 
Data described in literature for methanolic extract (15 mg GAE/g dry weight, 9 mg 
CE/g and DPPH EC50=53 µg/mL; Falleh et al., 2008), methanol:water (50:50, v:v) 
extract (50 mg GAE/g; Jimènez-Escrig et al., 2003), ethyl acetate extract (203 mg 
GAE/g and  DPPH EC50=22 µg/mL; Kubić et al., 2008), buthanol extract (62 mg 
GAE/g and  DPPH EC50=127 µg/mL; Kubić et al., 2008), ethanol extract (50 mg 
GAE/g and  DPPH EC50=157 µg/mL; Kubić et al., 2008) and water extract (46 mg 
GAE/g and  DPPH EC50=173 µg/mL; Kubić et al., 2008), indicate higher phenolics 
content and DPPH radical scavenging activity than the ones reported for the studied 
infusion. The opposite seem to be observed by Gouveia and Castilho (2012) in 
ultrasound-assisted methanolic extract (0.23 mg GAE/g) and by Lutz et al. (2011) in 
aqueous and hydroalcoholic extracts (~30% of DPPH scavenging activity). 
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Nevertheless, it should be highlighted that most of the mentioned solvents present 
toxicity and do not mimetize the most consumed forms as previously stated. 
Costa et al. (2012) also described phenolics, flavonoids and DPPH scavenging activity 
in borututu infusion (1.4 mg GAE/100 mL, 0.34 mg epicatechin equivalents/100 mL 
and DPPH EC50=1.9 mg trolox equivalents/100 mL). 
In the present work, artichoke and borututu infusions demonstrated anti-hepatocellular 
carcinoma activity with GI50 values of 52 and 146 µg/mL, respectively, but artichoke 
showed toxicity in normal cells (72 µg/mL). Despite the lower activity of borututu 
infusion, this sample did not show any hepatotoxicity in normal cells (GI50 > 400 
µg/mL); milk thistle also did not reveal toxicity in normal liver cells (Table 1). 
As can be observed in Table 3, the bioactive properties (antioxidant and antitumour) of 
the infusions were positively correlated (p<0.05) with phenolics and flavonoids content. 
 
3.2. Bioactive compounds, antioxidant activity and hepatotoxicity of the dietary 
supplements  
Regarding dietary supplements, the amount of bioactive compounds and the degree of 
antioxidant activity was as follows: borututu > milk thistle > artichoke. These samples 
neither revealed anti-hepatocelullar carcinoma activity (HepG2 GI50 value>400 µg/mL), 
nor toxicity for normal liver cells (PLP2 GI50 value>400 µg/mL) (Table 2).   
The biological activity of the dietary supplements was positively correlated (p<0.05) 
with the total phenolics and flavonoids content (Table 3), with the exception of 
phenolics/DPPH scavenging activity, flavonoids/reducing power and 
flavonoids/TBARS inhibition correlations.    
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Overall, all the samples revealed antioxidant properties with EC50 values lower than the 
daily recommended dose, but infusions showed higher antioxidant activity than dietary 
supplements. This in agreement with Gouveia and Castilho (2012) that reported a 
decrease in antioxidant potential of artichoke dietary supplements due to the absence of 
phenolic compounds. Borututu infusion gave the highest antioxidant activity, and also 
revealed anti-hepatocellular carcinoma activity without toxicity in non-tumour liver 
cells. On the contrary, artichoke infusion presented the highest antitumour activity but 
with toxicity for normal cells.  
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Table 1. Bioactive compounds, antioxidant activity and hepatotoxicity of the infusions. 
 
*Trolox and ellipticine for antioxidant and hepatotoxicity assays, respectively. EC50 
values correspond to the sample concentration achieving 50% of antioxidant activity or 
0.5 of absorbance in reducing power assay. GI50 values correspond to the sample 
concentration achieving 50% of growth inhibition in HepG2 human hepatocellular 
carcinoma cell line or in liver primary culture PLP2. In each row different letters mean 
significant differences (p<0.05). 
 
Cynara scolymus 
(Artichoke) 
Silybum marianum  
(Milk thistle) 
Cochlospermum angolensis  
 (Borututu) 
Positive  
control* 
Bioactive compounds 
Total phenolics (mg GAE/g) 20.82 ± 0.10b 23.26 ± 0.22b 132.26 ± 1.04a - 
Total flavonoids (mg CE/g) 4.37 ± 0.05c 6.95 ± 0.23b 17.88 ± 0.22a - 
Antioxidant activity (EC50 values, mg/mL) 
DPPH scavenging activity  2.13 ± 0.41a 2.45 ± 0.18a 0.15 ± 0.01b 0.04 ± 0.00 
Reducing power  1.81 ± 0.07a 1.73 ± 0.03a 0.17 ± 0.00b 0.03 ± 0.00 
β-carotene bleaching inhibition  1.69 ± 0.19a 1.36 ± 0.08b 0.62 ± 0.10c 0.003 ± 0.00 
TBARS inhibition  0.14 ± 0.00b 0.35 ± 0.00a 0.02 ± 0.00c 0.004 ± 0.00 
Anti-hepatocellular carcinoma activity  ( GI50 values, µg/mL) 
HepG2 (hepatocellular carcinoma) 52.06 ± 4.62b >400 146.06 ± 10.58a 3.22 ± 0.67 
Hepatotoxicity ( GI50 values, µg/mL) 
PLP2 (non-tumour liver primary culture) 71.73 ± 5.88 >400 >400 2.06 ± 0.03 
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Table 2. Bioactive compounds, antioxidant activity and hepatotoxicity of the dietary 
supplements. 
 
*Trolox and ellipticine for antioxidant and hepatotoxicity assays, respectively. EC50 
values correspond to the sample concentration achieving 50% of antioxidant activity or 
0.5 of absorbance in reducing power assay. GI50 values correspond to the sample 
concentration achieving 50% of growth inhibition in HepG2 human hepatocellular 
carcinoma cell line or in liver primary culture PLP2. n.p.- not possible to determine. In 
each row different letters mean significant differences (p<0.05). 
 
Cynara scolymus 
(Artichoke) 
Silybum marianum  
(Milk thistle) 
Cochlospermum angolensis  
 (Borututu) 
Positive  
control* 
Bioactive compounds 
Total phenolics (mg GAE/g) 3.35 ± 0.01c 20.92 ± 0.45b 30.70 ± 0.79a - 
Total flavonoids (mg CE/g) 2.83 ± 0.10c 3.88 ± 0.13b 5.65 ± 0.03a - 
Antioxidant activity (EC50 values, mg/mL) 
DPPH scavenging activity  10.14 ± 0.58a 8.18 ± 0.46b 1.27 ± 0.01c 0.04 ± 0.00 
Reducing power  2.28 ± 0.09a 1.10 ± 0.02b 0.58 ± 0.01c 0.03 ± 0.00 
β-carotene bleaching inhibition  n.p. 17.72 ± 0.57a 5.62 ± 0.66b 0.003 ± 0.00 
TBARS inhibition  1.49 ± 0.05a 0.78 ± 0.03b 0.34 ± 0.05c   0.004 ± 0.00 
Anti-hepatocellular carcinoma activity  ( GI50 values, µg/mL) 
HepG2 (hepatocellular carcinoma) >400 >400 >400 3.22 ± 0.67 
Hepatotoxicity ( GI50 values, µg/mL) 
PLP2 (non-tumour liver primary culture) >400 >400 >400 2.06 ± 0.03 
A B 
C 
A B 
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Table 3. Correlations established between total phenolics, total flavonoids, antioxidant activity EC50 values and anti-hepatocellular 
carcinoma activity GI50 values of the infusions and dietary supplements. 
  Infusions Dietary supplements 
 Phenolics (mg GAE/g) Flavonoids  (mg CE/g) Phenolics (mg GAE/g) Flavonoids  (mg CE/g) 
DPPH scavenging activity 
EC50 value (mg/mL) 
Linear equation Y= -0.0194x+2.7156 Y= -0.1653x+3.1871 Y= 0.626x+2.445 Y= 15.319x-56.167 
R2 0.9246 0.8570 0.3078 0.9288 
Reducing power 
EC50 value (mg/mL) 
Linear equation Y= -0.0144x+2.0805 Y= -0.1266x+2.4657 Y=-0.0498x+2.2389 Y= -0.0289x+1.4481 
R2 0.9970 0.9774 0.6047 0.3001 
β-carotene bleaching inhibition 
EC50 value (mg/mL) 
Linear equation Y=-0.0083x+1.7099 Y= -0.0757x+1.9611 Y=1.2166x-19.730 Y= 6.7664x-20.581 
R2 0.8551 0.9117 0.9718 0.9861 
TBARS inhibition 
EC50 value (mg/mL) 
Linear equation Y=-0.0004x+0.0563 Y= -0.0041x+0.0719 Y= -0.0426x+1.6595 Y= -0.3914x+2.6643 
R2 0.5447 0.6874 0.9885 0.4208 
HepG2 
GI50 value (µg/mL) 
Linear equation Y= 0.8434x+34.512 Y= 6.9512x+21.71 - - 
R2 0.9899 0.9892 - - 
 
 
 
